AkhondzadehS, TabatabaeeM, AminiH, Ahmadi AbhariSA, AbbasiSH, BehnamB. Celecoxib as adjunctive therapy in schizophrenia: A double-blind, randomized and placebo-controlled trial. Schizophr Res, 90:179–185. 2007.
2.
ChaudhryIB, HallakJ, HusainN, MinhasF, StirlingJ, RichardsonP, DursunS, DunnG, DeakinB. Minocycline benefits negative symptoms in early schizophrenia: A randomised double-blind placebo-controlled clinical trial in patients on standard treatment. J Psychopharmacol, 26:1185–1193. 2012.
3.
KhandakerGM, ZimbronJ, LewisG, JonesPB. Prenatal maternal infection, neurodevelopment and adult schizophrenia: A systematic review of population-based studies. Psychol Med, 43:239–257. 2013.
4.
KhashanAS, AbelKM, McNameeR, PedersenMG, WebbRT, BakerPN, KennyLC, MortensenPB. Higher risk of offspring schizophrenia following antenatal maternal exposure to severe adverse life events. Arch Gen Psychiatry, 65:146–152. 2008.
5.
LaanW, GrobbeeDE, SeltenJP, HeijnenCJ, KahnRS, BurgerH. Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: Results from a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry, 71:520–527. 2010.
6.
MullerN, KrauseD, DehningS, MusilR, Schennach-WolffR, ObermeierM, MöllerHJ, KlaussV, SchwarzMJ, RiedelM. Celecoxib treatment in an early stage of schizophrenia: Results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment. Schizophr Res, 121:118–124. 2010.
7.
MullerN, RiedelM, ScheppachC, BrandstätterB, SokulluS, KrampeK, UlmschneiderM, EngelRR, MöllerHJ, SchwarzMJ. Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia. Am J Psychiatry, 159:1029–1034. 2002.
8.
NawaH, YamadaK. Experimental schizophrenia models in rodents established with inflammatory agents and cytokines. Methods Mol Biol, 829:445–451. 2012.
